# Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration

> **NCT00944541** · PHASE2 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 60 (actual)

## Conditions studied

- HIV Infection
- HIV Infections

## Interventions

- **DRUG:** maraviroc

## Key facts

- **NCT ID:** NCT00944541
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-08
- **Final completion:** 2011-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944541, "Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT00944541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*